-
Walgreens sees top-line growth in second quarter
Despite expected headwinds from slower generic drug introductions, comparisons with last year's flu season and severe weather, Walgreens saw solid top-line growth in the second quarter ended Feb. 28, driven by record quarterly sales and record second-quarter prescriptions filled.
The company also continued to gain prescription market share while maintaining a firm hold on its costs.
Walgreens posted a sales increase of 5.1% to $19.6 billion for the quarter. First half sales were up 5.5% to $37.9 billion.
-
Five Below sees improving trends in challenging fourth quarter
A severe winter may have affected sales results for many retailers, but Five Below saw improving trends as it weathered the fourth quarter.
Net sales increased by 22% to $212 million from $173.6 million in the prior-year quarter, which consisted of 14 weeks. Comparable-store sales increased by 0.3% on a 13-week basis.
The company ended the quarter with 304 stores in 19 states, an increase of 25% from the end of the prior-year quarter.